🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yu Zhang

Broad Institute

ORCID: 0000-0003-3643-6589

Also affiliated with Harvard University, Massachusetts Institute of Technology

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager”.

Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager

Frontiers in Pharmacology(2023)10.3389/fphar.2023.1163432

N/A

0.529DataRank · unranked

33 citations

Hanwen Wang, Yu Zhang, Jun Wang, Minu Pilvankar, Masoud Nickaeen +3 more

Dynamic Multiscale Regulation of Perfusion Recovery in Experimental Peripheral Arterial Disease

JACC Basic to Translational Science(2022)10.1016/j.jacbts.2021.10.014

N/A

0.425DataRank · unranked

16 citations

Joshua L. Heuslein, Yu Zhang, Brian H. Annex, Aleksander S. Popel, Chen Zhao

A systems biology model of junctional localization and downstream signaling of the Ang–Tie signaling pathway

npj Systems Biology and Applications(2021)10.1038/s41540-021-00194-6

N/A

0.406DataRank · unranked

14 citations

Christopher D. Kontos, Brian H. Annex, Aleksander S. Popel, Yu Zhang

Eliciting the antitumor immune response with a conditionally activated PD‐L1 targeting antibody analyzed with a quantitative systems pharmacology model

CPT Pharmacometrics & Systems Pharmacology(2023)10.1002/psp4.13060

N/A

0.373DataRank · unranked

11 citations

Hanwen Wang, Yu Zhang, Vahideh Vakil, Hojjat Bazzazi, Aleksander S. Popel +1 more

Virtual clinical trials via a QSP immuno-oncology model to simulate the response to a conditionally activated PD-L1 targeting antibody in NSCLC

Journal of Pharmacokinetics and Pharmacodynamics(2024)10.1007/s10928-024-09928-5

N/A

0.373DataRank · unranked

11 citations

Hanwen Wang, Yu Zhang, Vahideh Vakil, Aleksander S. Popel, Alberto Ippolito

Endothelial Regulation of Microvascular Growth and Stability by Ang‐Tie and VEGF Signaling Pathways: A Mechanistic Computational Systems Biology Model

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r2072

N/A

0DataRank · unranked

1 citations

Christopher D. Kontos, Brian H. Annex, Aleksander S. Popel, Yu Zhang

Computational Systems Biology Modeling of the Angiopoietin‐Tie Signaling Pathway and its Crosstalk with α5β1 Integrin in Endothelial Cells

The FASEB Journal(2021)10.1096/fasebj.2021.35.s1.02368

N/A

0DataRank · unranked

0 citations

Christopher D. Kontos, Brian H. Annex, Aleksander S. Popel, Yu Zhang

Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies

ACS Pharmacology & Translational Science(2023)10.1021/acsptsci.3c00008

N/A

0DataRank · unranked

18 citations

Aleksander S. Popel, Hojjat Bazzazi, Yu Zhang

Signaling-biophysical modeling unravels mechanistic control of red blood cell phagocytosis by macrophages in sickle cell disease

PNAS Nexus(2024)10.1093/pnasnexus/pgae031

N/A

0DataRank · unranked

11 citations

Yuhao Qiang, He Li, Guansheng Li, Lu Lu, Ming Dao +4 more